Insider · CIK 0001609480
Cynthia Smith
director
Files at TVRD (Tvardi Therapeutics, Inc.), TARA (Protara Therapeutics, Inc.), AGIO (AGIOS PHARMACEUTICALS, INC.), AKBA (Akebia Therapeutics, Inc.), SPRO (Spero Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock | +2,302 | $0.00 | $0 | 12,414 | Aug 13, 2025 |
| Aug 11, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative | -2,302 | $0.00 | $0 | 0 | Aug 13, 2025 |
| Jun 20, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock | +2,120 | $0.00 | $0 | 10,112 | Jun 23, 2025 |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative | +2,816 | $0.00 | $0 | 2,816 | Jun 23, 2025 |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative | +15,768 | $0.00 | $0 | 15,768 | Jun 23, 2025 |
| Jun 20, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative | -2,120 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 12, 2025 | SPRO Spero Therapeutics, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 75,000 | Jun 16, 2025 |
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 13, 2025 |
| Jun 10, 2025 | AKBA Akebia Therapeutics, Inc. | AGrant or award Common Stock | +35,700 | $0.00 | $0 | 160,933 | Jun 11, 2025 |
| Jun 10, 2025 | AKBA Akebia Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +53,600 | $0.00 | $0 | 53,600 | Jun 11, 2025 |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Apr 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.